Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,494 | 23,350 | 25,088 | 19,226 | 29,332 |
| Receivables | 152,898 | 208,143 | 206,616 | 202,717 | 177,953 |
| Inventories | 40,906 | 43,371 | 46,821 | 49,265 | 53,214 |
| Other current assets | 10,196 | 12,710 | 12,215 | 10,740 | 12,029 |
| TOTAL | $238,547 | $301,820 | $303,868 | $296,907 | $286,548 |
| Non-Current Assets | |||||
| PPE Net | 143,211 | 149,014 | 138,824 | 125,418 | 115,295 |
| Intangibles | 188,200 | 175,106 | 174,286 | 172,058 | 171,008 |
| Other Non-Current Assets | 55,300 | 47,385 | 44,032 | 42,133 | 38,022 |
| TOTAL | $386,711 | $371,505 | $357,142 | $339,609 | $324,325 |
| Total Assets | $625,258 | $673,325 | $661,010 | $636,516 | $610,873 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33,474 | 47,084 | 50,821 | 55,168 | 57,639 |
| Accrued Expenses | 36,475 | 34,617 | 38,969 | 34,919 | 34,028 |
| Other current liabilities | 25,480 | 19,624 | N/A | N/A | N/A |
| TOTAL | $120,758 | $131,866 | $135,775 | $140,510 | $143,195 |
| Non-Current Liabilities | |||||
| Long Term Debt | 430,987 | 353,672 | 267,002 | 234,033 | 223,075 |
| Deferred Revenues | 14,101 | 11,009 | 10,887 | 13,868 | 19,154 |
| Other Non-Current Liabilities | 92,246 | 85,443 | 79,591 | 66,742 | 57,457 |
| TOTAL | $528,199 | $447,466 | $355,846 | $308,093 | $286,023 |
| Total Liabilities | $648,957 | $579,332 | $491,621 | $448,603 | $429,218 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,376 | 43,322 | 44,856 | 46,226 | 47,621 |
| Common Shares | 1,142 | 1,174 | 1,203 | 1,233 | 1,262 |
| Retained earnings | 219,207 | 415,906 | 415,930 | 361,255 | 283,660 |
| Other shareholders' equity | -5,048 | -5,087 | -2,744 | -2,575 | 1,607 |
| TOTAL | $-23,699 | $93,993 | $169,389 | $187,913 | $181,655 |
| Total Liabilities And Equity | $625,258 | $673,325 | $661,010 | $636,516 | $610,873 |